Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment

Introduction Several antiretroviral drugs are being considered for the treatment of COVID‐19, the disease caused by a newly identified coronavirus, (SARS‐CoV‐2). We systematically reviewed the clinical outcomes of using antiretroviral drugs for the prevention and treatment of coronaviruses and plann...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the International AIDS Society Vol. 23; no. 4; pp. e25489 - n/a
Main Authors:	Ford, Nathan, Vitoria, Marco, Rangaraj, Ajay, Norris, Susan L, Calmy, Alexandra, Doherty, Meg
Format:	Journal Article
Language:	English
Published:	Switzerland John Wiley & Sons, Inc 01.04.2020 John Wiley and Sons Inc
Subjects:	Adult Anti-Retroviral Agents - therapeutic use antiretroviral therapy Antiretroviral Therapy, Highly Active Antiviral agents Atazanavir Betacoronavirus China Control coronavirus Coronavirus - drug effects Coronavirus - isolation & purification Coronavirus infections Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology Coronaviruses COVID-19 COVID-19 Drug Treatment Darunavir Development and progression Dosage and administration Drug Combinations Drug therapy Drugs Efavirenz Emtricitabine Epidemics Female Health aspects Highly active antiretroviral therapy HIV HIV (Viruses) Humans Lopinavir Male Medical research Medicine, Experimental MERS Middle Aged Pandemics Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Prevention Review Reviews Risk factors Ritonavir SARS SARS-CoV-2 Severe Acute Respiratory Syndrome - drug therapy Severe Acute Respiratory Syndrome - epidemiology Severe acute respiratory syndrome-related coronavirus - drug effects Middle East South Korea China COVID-19 SARS coronavirus HIV MERS antiretroviral therapy
ISSN:	1758-2652, 1758-2652
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!